U.S. Consumer Durables Stock News

Zillow Group (ZG) just posted its third-quarter earnings, revealing a swing to profitability and double-digit revenue growth compared to last year. The company also reaffirmed full-year guidance and shared a positive outlook for the upcoming quarter. See our latest analysis for Zillow Group. After a year marked by new features and steady innovation, Zillow Group’s financial momentum appears to be catching the market’s eye. The stock is now trading at $70.81, with a modest 2.79% share price...

Merit Medical Systems (MMSI) saw attention after unveiling positive 24-month results from the WAVE trial for its WRAPSODY Cell-Impermeable Endoprosthesis. The data, announced during a leading vascular conference, showed the device’s superior performance compared to standard treatment. See our latest analysis for Merit Medical Systems. After a tough year for total shareholders, news like the positive WAVE trial results is sparking fresh interest. Merit’s share price has climbed 4.6% over the...

Earlier this month, PPG Industries introduced a new ultrafiltration antifouling membrane for industrial water purification, designed to handle complex oily waste streams and other tough contaminants without intentionally-added PFAS. This launch highlights PPG's focus on sustainable innovation in water treatment technology, adding to its production capabilities and broad industrial applications. Let's explore how PPG's investment in next-generation water filtration could shape its growth and...

MDU Resources Group (MDU) has delivered a strong stretch of returns over the past year, gaining 20% in that time and building further momentum in recent months. Investors are now weighing what comes next for this diversified infrastructure company. See our latest analysis for MDU Resources Group. The past year has been a strong one for MDU Resources Group, with its latest share price pushing to $20.90 and recent momentum especially visible over the last month. The stock’s 1-year total...

NETSTREIT Corp. recently reported third quarter 2025 results, posting US$45.03 million in sales and a net income of US$618,000, a turnaround from a net loss in the prior year period. The Board of Directors declared a quarterly cash dividend increase, taking the annualized payout to US$0.86 per share, signaling confidence in the company's ongoing earnings recovery. We will now examine how the improved profitability and increased dividend inform NETSTREIT’s investment outlook and risk...

Insmed Incorporated recently reported a third quarter net loss of US$370.02 million but raised its 2025 global ARIKAYCE revenue guidance to between US$420 million and US$430 million, signifying higher growth expectations for the product. This updated revenue outlook comes despite an increase in net loss for both the quarter and year-to-date, highlighting expansion in ARIKAYCE demand even as overall losses continue to widen. We'll examine how the improved ARIKAYCE revenue forecast shapes...

Kite Realty Group Trust (KRG) just wrapped up an eventful stretch, rolling out third quarter earnings, issuing fresh net income guidance for 2025, increasing its fourth quarter dividend by 7%, and completing a significant share buyback. See our latest analysis for Kite Realty Group Trust. While Kite Realty Group Trust’s latest share buyback, updated guidance, and dividend boost have caught investors’ attention, the stock’s momentum has yet to shift meaningfully. The year-to-date share price...

Federal Agricultural Mortgage, fresh off announcing higher net income and earnings per share for the third quarter and year-to-date period, is also rewarding shareholders with affirmed dividends across its common and preferred stock classes. These actions highlight consistent financial momentum and a commitment to shareholder returns. See our latest analysis for Federal Agricultural Mortgage. After the encouraging earnings and dividend affirmations, Federal Agricultural Mortgage’s share price...

Earlier this week, Johnson & Johnson announced it received U.S. FDA approvals for DARZALEX FASPRO® as a single-agent treatment for high-risk smoldering multiple myeloma and for CAPLYTA as an adjunctive therapy in major depressive disorder. The DARZALEX FASPRO® approval marks the first FDA-authorized therapy for early-stage HR-SMM, and expands Johnson & Johnson's offerings in oncology and psychiatric medicines based on robust Phase 3 trial data. We'll explore how these recent FDA approvals...

Arrowhead Pharmaceuticals is approaching a key FDA decision on November 18, 2025, for its RNAi therapy Plozasiran targeting familial chylomicronemia syndrome, following strong efficacy in Phase 3 trials with substantial reduction in triglycerides and pancreatitis risk. Additionally, Novartis has announced a global licensing agreement for development of ARO-SNCA, bringing Arrowhead significant upfront payments and milestone opportunities that strengthen its financial position before potential...

Vornado Realty Trust recently reported its third-quarter 2025 results, achieving a turnaround with net income of US$27.12 million compared to a net loss a year earlier, supported by revenue of US$453.7 million and key gains from property transactions including a master lease with New York University. Investor interest was further fueled by Vornado's strong leasing activity in Manhattan, acquisition and redevelopment plans for 623 Fifth Avenue, and expectations for increased Penn District...

Capital Southwest (CSWC) just posted earnings that topped expectations, completing a busy quarter that included new investments and a $350 million bond raise. The company also declared regular and supplemental dividends for shareholders. See our latest analysis for Capital Southwest. After a strong earnings beat and a successful $350 million bond raise, Capital Southwest’s momentum has started to gain traction. The share price recently saw a modest rebound, up nearly 2% over the past week to...

Brown & Brown, Inc. recently announced its third quarter 2025 results, reporting revenue of US$1.61 billion and net income of US$227 million, alongside an active acquisition outlook according to their CEO's commentary on seeking both domestic and international deals. While revenue increased compared to the prior year, net income saw a slight decline and the company paused share repurchases for this period, completing earlier buybacks totaling over 16.5 million shares. Given the CEO's ongoing...

Nexstar Media Group (NXST) shares edged up slightly today, catching the eye of investors after a mostly flat week and a modest month-long dip. With the company showing stable annual revenue and net income growth, some are revisiting their outlook. See our latest analysis for Nexstar Media Group. Nexstar’s share price has cooled a bit recently, but the bigger picture is hard to ignore. After a strong rally year to date and a 19.7% total shareholder return over the past year, momentum is still...

Dyne Therapeutics reported its third quarter and nine-month financial results for the period ended September 30, 2025, posting a net loss of US$108.04 million for the quarter and US$334.26 million for the nine months. The company is also set to present updates and engage with the investment community at several major healthcare investor conferences through the end of 2025. We'll explore how the widening net loss shapes Dyne Therapeutics' investment narrative amid ongoing engagement with the...

Crinetics Pharmaceuticals recently announced the U.S. FDA approval and commercial launch of PALSONIFY (paltusotine) for treating adults with acromegaly, reporting early metrics of prescription uptake and field force coverage. This milestone marks Crinetics' transition to a commercial-stage company, supported by a strong cash position expected to fund operations into 2029 and ongoing advances in its clinical pipeline. With early signs of PALSONIFY’s market acceptance, we’ll explore how this...

Alexander & Baldwin, Inc. recently amended its US$450 million revolving credit facility, adding a new term loan facility of up to US$200 million, and raised its 2025 earnings guidance to a range of US$0.95 to US$1 per diluted share. These developments point to a focus on both financial flexibility and growth opportunities, particularly as the company actively searches for acquisitions in Hawaii’s competitive investment market. Let's examine how the creation of this new term loan facility...

PJT Partners reported record third-quarter and nine-month financial results, with revenue reaching US$447.09 million and net income at US$39.84 million, while the board declared a quarterly dividend of US$0.25 per share payable on December 17, 2025. The firm’s expansion in advisory fee mandates, alongside its top ranking in U.S. restructuring advisory, highlighted its strong position amid a rebound in M&A activity. We’ll explore how the sharp growth in advisory fees and expanded team could...

Wondering if now is the right time to pick up shares of Home Depot? You are not alone, as many investors are keeping a close eye on its valuation and growth story. Recently, Home Depot's stock has seen some turbulence, losing 2.2% over the past week and 3.3% in the last month. This has contributed to a 4.5% slide year-to-date. Much of this movement is happening as the company navigates changes in consumer spending and shifting trends in the DIY market. Recent headlines have highlighted the...

Penumbra (PEN) shares have been performing steadily in recent weeks, with the stock up about 17% over the past week and around 3% for the month. Investors are watching closely to see if this momentum continues as the broader healthcare sector evolves. See our latest analysis for Penumbra. Momentum has definitely picked up for Penumbra lately, with the share price jumping over 17% in the past week and adding to a healthy year-to-date gain. Even after some ups and downs, Penumbra’s 12.6% total...

Copart (CPRT) has continued to attract investor attention given its performance over the month, with shares recently closing at $40.51. The company’s business metrics and year-to-date moves are fueling new conversations about current valuation. See our latest analysis for Copart. After a strong run in previous years, Copart’s share price momentum has cooled in 2024, with a 1-day gain of 1.33% offering little relief from its year-to-date decline of 28.07%. Despite this, long-term shareholders...

Reynolds Consumer Products (REYN) stock is attracting renewed attention as recent performance numbers reveal an interesting mix of steady revenue growth and improving net income. Investors are naturally weighing how these trends could influence shares in the months ahead. See our latest analysis for Reynolds Consumer Products. After a choppy start to the year, Reynolds Consumer Products has seen its share price find firmer footing, climbing nearly 9% across the last 90 days as fundamentals...

Preferred Bank recently delivered a strong quarterly report, surpassing analyst expectations with a 3.7% year-over-year revenue increase and a quarterly record diluted earnings per share of US$2.84 for Q3 2025, resulting in net income of US$35.9 million. This performance is particularly significant as it highlights Preferred Bank's resilience and operational strength amid ongoing challenges in the broader regional banking sector. Given the record earnings per share achievement, we'll explore...

Welltower (WELL) shares have seen steady gains through the past month, catching the eye of investors interested in real estate stocks. As the company navigates shifting market dynamics, its recent performance raises questions about long-term valuation. See our latest analysis for Welltower. Momentum has clearly picked up for Welltower this year, with the company’s share price returning 52.54% year-to-date and trading at $190.25. When you factor in dividends, the total shareholder return...